Year None20222021202020192018201720162015201420132012 10.21.2021 Iveric Bio Announces Proposed Offering of Common Stock 10.04.2021 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 09.10.2021 Iveric Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference 09.02.2021 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 08.10.2021 Iveric Bio to Present at the H.C. Wainwright Ophthalmology Virtual Conference 08.04.2021 Iveric Bio to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 11, 2021 08.04.2021 Iveric Bio Reports Second Quarter 2021 Operational Highlights and Financial Results 08.03.2021 Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 07.28.2021 Iveric Bio to Report Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021 07.26.2021 Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura® Ahead of Schedule Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
